KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $154.6 million.

  • Emergent BioSolutions' Operating Expenses fell 3257.74% to $154.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $670.4 million, marking a year-over-year decrease of 4715.02%. This contributed to the annual value of $1.2 billion for FY2024, which is 3510.73% down from last year.
  • According to the latest figures from Q3 2025, Emergent BioSolutions' Operating Expenses is $154.6 million, which was down 3257.74% from $139.3 million recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Operating Expenses ranged from a high of $630.8 million in Q2 2023 and a low of $139.3 million during Q2 2025
  • Over the past 5 years, Emergent BioSolutions' median Operating Expenses value was $311.9 million (recorded in 2023), while the average stood at $321.7 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first soared by 10044.49% in 2023, then plummeted by 6959.84% in 2025.
  • Over the past 5 years, Emergent BioSolutions' Operating Expenses (Quarter) stood at $437.9 million in 2021, then decreased by 11.97% to $385.5 million in 2022, then dropped by 16.89% to $320.4 million in 2023, then plummeted by 36.27% to $204.2 million in 2024, then dropped by 24.29% to $154.6 million in 2025.
  • Its Operating Expenses was $154.6 million in Q3 2025, compared to $139.3 million in Q2 2025 and $172.3 million in Q1 2025.